LGD-4033
产品编号: DC7633
Featured
我们的合作伙伴:
中国地区超过5000个高品质化合物库存
应用领域
LGD-4033是一种新型的非类固醇, 口服SARM, 以高亲和力 (Ki为1 nM) 和选择性与雄激素受体结合。
| Cas No.: |
1165910-22-4 |
| 名称: |
4-[(2R)-2-[(1R)-2,2,2-trifluoro-1-hydroxyethyl]pyrrolidin-1-yl]-2-(trifluoromethyl)benzonitrile |
| 别名: |
LGD4033, 4-((R)-2-((R)-2,2,2-Trifluoro-1-hydroxyethyl)pyrrolidin-1-yl)-2-(trifluoromethyl)benzonitrile |
| SMILES: |
C(#N)C1=CC=C(N2CCC[C@H]2[C@H](O)C(F)(F)F)C=C1C(F)(F)F |
| 分子式: |
C14H12F6N2O |
| 分子量: |
338.248299 |
| 纯度: |
|
| 保存条件: |
2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
| Description: |
|
| In Vivo: |
|
| In Vitro: |
|
| References: |
Pre-clinical Modeling of LGD-4033 Efficacy: In castrated male rats,LGD-4033 increased levator ani muscle weight in a dose dependent manner when administered via continuous release osmotic minipump. Osmotic minipump dosing was utilized to mimic the long ha |
| Kinase Assay: |
|
| Cell Assay: |
|
| Animal Administration: |
|
| References: |
|
MSDS
| TITLE |
DOWNLOAD |
| MSDS_1865_DC7633_1165910-22-4 |
|
COA
| LOT NO. |
DOWNLOAD |
|
|
询盘
